Hacer Demir

Afyonkarahisar, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 62 publications

Prognostic factors in avelumab maintenance therapy for metastatic urothelial carcinoma.

Prognostic factors in avelumab maintenance therapy for metastatic urothelial carcinoma.

Journal: Immunotherapy

Published: September 02, 2026

Palliative Care Awareness Among Caregivers of Cancer Patients in Turkey: A Cross-Sectional Study.

Palliative Care Awareness Among Caregivers of Cancer Patients in Turkey: A Cross-Sectional Study.

Journal: Current oncology (Toronto, Ont.)

Published: June 16, 2026

Aprepitant and Fosaprepitant for Preventing Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy-A Real-World Study.

Aprepitant and Fosaprepitant for Preventing Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy-A Real-World Study.

Journal: Current oncology (Toronto, Ont.)

Published: May 13, 2026

Hematological Changes Associated with Thrombotic Events in Cancer Patients: A Retrospective Exploratory Study.

Hematological Changes Associated with Thrombotic Events in Cancer Patients: A Retrospective Exploratory Study.

Journal: Journal of clinical medicine

Published: April 17, 2026

Correction: Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer.

Correction: Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer.

Journal: Scientific reports

Published: April 03, 2026

Assessing Early Treatment Response in mCSPC Using KELIM PSA Score: Implications for Survival.

Assessing Early Treatment Response in mCSPC Using KELIM PSA Score: Implications for Survival.

Journal: Urologia internationalis

Published: March 26, 2026

Prevalence and Reactivation of Hepatitis B and C in Patients Undergoing Chemotherapy for Solid Tumors.

Prevalence and Reactivation of Hepatitis B and C in Patients Undergoing Chemotherapy for Solid Tumors.

Journal: JCO global oncology

Published: March 19, 2026

Does the Duration of FLOT Infusion Change the Outcome of Perioperative Treatment for Gastric Cancer? Comparing 24- and 48-h Infusions.

Does the Duration of FLOT Infusion Change the Outcome of Perioperative Treatment for Gastric Cancer? Comparing 24- and 48-h Infusions.

Journal: Medicina (Kaunas, Lithuania)

Published: March 03, 2026

Tyrosine Kinase Inhibitor Therapy in Metastatic Medullary Thyroid Carcinoma: Real-World Data from Turkish Oncology Group.

Tyrosine Kinase Inhibitor Therapy in Metastatic Medullary Thyroid Carcinoma: Real-World Data from Turkish Oncology Group.

Journal: Journal of clinical medicine

Published: March 01, 2026

The Effect of HER3 Expression on Prognosis in EGFR-Mutant Non-Small Cell Lung Cancer: A Retrospective Real-World Study.

The Effect of HER3 Expression on Prognosis in EGFR-Mutant Non-Small Cell Lung Cancer: A Retrospective Real-World Study.

Journal: Medicina (Kaunas, Lithuania)

Published: February 22, 2026

Outcomes of First-Line PARP Inhibitor Therapy in Ovarian Cancer: A Multicenter Retrospective Analysis.

Outcomes of First-Line PARP Inhibitor Therapy in Ovarian Cancer: A Multicenter Retrospective Analysis.

Journal: Journal of clinical medicine

Published: February 01, 2026

Bone Metastasis Distribution Matters: Prognostic Effect of the Axial-to-Peripheral Ratio in Metastatic Hormone-Sensitive Prostate Cancer.

Bone Metastasis Distribution Matters: Prognostic Effect of the Axial-to-Peripheral Ratio in Metastatic Hormone-Sensitive Prostate Cancer.

Journal: The Prostate

Published: January 26, 2026

Showing 1-12 of 62

Last Updated: 09/26/2026